SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001741830-23-000010
Filing Date
2023-03-15
Accepted
2023-03-15 16:06:20
Documents
14
Period of Report
2023-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kron-20230315.htm   iXBRL 8-K 30009
5 kronosbio1a.jpg GRAPHIC 30771
6 EX-99.1 kronosq42022ex-991.htm EX-99.1 60358
  Complete submission text file 0001741830-23-000010.txt   272020

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20230315.xsd EX-101.SCH 1918
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20230315_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20230315_pre.xml EX-101.PRE 13060
8 EXTRACTED XBRL INSTANCE DOCUMENT kron-20230315_htm.xml XML 4270
Mailing Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 400 SAN MATEO CA 94402 (650) 781-5200
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 23735192
SIC: 2834 Pharmaceutical Preparations